Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Artificial Intelligence & Technology ETF (AIQ) vs Nuwellis Inc (NUWE) Price & Performance

Global X Artificial Intelligence & Technology ETFTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Global X Artificial Intelligence & Technology ETF vs Nuwellis Inc — how do they compare? Global X Artificial Intelligence & Technology ETF trades at $63.53, while Nuwellis Inc trades at $1.4 (market cap $542.80K). The key difference: Global X Artificial Intelligence & Technology ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

AIQNUWE
Sector
Sector/ThematicTechnology
52-Week High
$70.14$220.50
52-Week Low
$43.88$1.42
Market Cap
$542.80K
Enterprise Value
-$1.27M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Artificial Intelligence & Technology ETF

AIQ trades at $63.69, up 0.28% today, with a bullish technical signal from moving averages and a neutral stance from oscillators. The stock recently crossed above its 200-day moving average of $56.52, indicating positive momentum. Recent news highlights AIQ's outperformance versus the Nasdaq and its role in the AI investment theme, though financial ratios are not provided in the snapshot.

The outlook for AIQ is tied to the AI sector's growth, with potential from thematic exposure and rebalancing strategies. Risks include high fees, sector volatility, and dependence on AI adoption trends. Analyst sentiment is mixed, with some praising diversification benefits while others note valuation concerns amid rapid gains.

Nuwellis Inc

NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.

Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X Artificial Intelligence & Technology ETF

AIQ invests in companies that benefit from the development and utilization of artificial intelligence. It focuses on hardware, software, and data giants at the center of the AI revolution, including NVIDIA, Meta, and Broadcom.

Read more on AIQ

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE